IFP Advisors, Inc - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$707,032
-33.7%
26,313
-42.6%
0.03%
+39.1%
Q2 2023$1,066,546
+266.8%
45,804
+71.9%
0.02%
+76.9%
Q1 2023$290,786
+88017.0%
26,653
-9.4%
0.01%
+44.4%
Q4 2022$330
-99.9%
29,417
+19.8%
0.01%
+28.6%
Q3 2022$277,000
+3.7%
24,560
+3.2%
0.01%
-12.5%
Q2 2022$267,000
-47.3%
23,789
-47.5%
0.01%
+33.3%
Q1 2022$507,000
-64.4%
45,308
+110.9%
0.01%
-78.6%
Q4 2021$1,424,000
+6.3%
21,482
+0.3%
0.03%
+3.7%
Q3 2021$1,340,000
-22.7%
21,412
+2.5%
0.03%
-25.0%
Q2 2021$1,734,000
+41.2%
20,895
+12.9%
0.04%
+50.0%
Q1 2021$1,228,000
-14.0%
18,503
-0.5%
0.02%
-58.6%
Q4 2020$1,428,000
+70.0%
18,598
-4.7%
0.06%
+16.0%
Q3 2020$840,000
+5.8%
19,522
+5.0%
0.05%
-20.6%
Q2 2020$794,000
+50.1%
18,589
+8.0%
0.06%
+18.9%
Q1 2020$529,000
-38.8%
17,207
+29.4%
0.05%
-18.5%
Q4 2019$864,000
+70.1%
13,297
-29.6%
0.06%
+91.2%
Q3 2019$508,000
+134.1%
18,896
+3.7%
0.03%
+161.5%
Q4 2018$217,000
+274.1%
18,216
+507.2%
0.01%
+550.0%
Q3 2018$58,000
+190.0%
3,000
+100.0%
0.00%
+100.0%
Q2 2018$20,000
+100.0%
1,500
-21.1%
0.00%0.0%
Q2 2016$10,0001,9000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,264$54,392,00033.22%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$216,228,00028.00%
L1 Capital Pty Ltd 296,024$19,629,0004.93%
Aquilo Capital Management, LLC 407,926$27,050,0004.89%
Evolutionary Tree Capital Management, LLC 72,948$4,837,0002.86%
ACUTA CAPITAL PARTNERS, LLC 108,000$7,161,0002.58%
First Light Asset Management, LLC 536,836$35,598,0002.36%
Parkman Healthcare Partners LLC 70,089$4,648,0001.08%
Hood River Capital Management LLC 357,082$23,678,0000.76%
Tygh Capital Management, Inc. 63,947$4,240,0000.60%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders